-
1Academic Journal
المؤلفون: Topilin, I, Zyryanov, V, Volodina, M
المصدر: IOP Conference Series: Materials Science and Engineering ; volume 698, issue 6, page 066046 ; ISSN 1757-8981 1757-899X
-
2Academic Journal
المؤلفون: A. Solodovnik A., H. Mkrtchyan S., V. Misyurin A., V. Tikhonova V., Yu. Finashutina P., N. Kasatkina N., O. Solopova N., O. Votyakova M., O. Yakimovich Yu., O. Volodina M., M. Kichigina Yu., E. Medvedovskaya G., A. Antipova S., I. Zavodnova Z., A. Semenova A., G. Arakelyan R., Yu. Ryabukhina E., O. Kolomeytsev A., A. Shirin D., E. Osmanov A., A. Misyurin V., А. Солодовник А., А. Мкртчян С., В. Мисюрин А., В. Тихонова В., Ю. Финашутина П., Н. Касаткина Н., О. Солопова Н., О. Вотякова М., О. Якимович Ю., О. Володина М., М. Кичигина Ю., Е. Медведовская Г., А. Антипова С., И. Заводнова З., А. Семенова А., Г. Аракелян Р., Ю. Рябухина Е., О. Коломейцев А., А. Ширин Д., Е. Османов А., А. Мисюрин В.
المساهمون: GeneTechnology, ООО «ГеноТехнология»
المصدر: Advances in Molecular Oncology; Том 5, № 2 (2018); 62-70 ; Успехи молекулярной онкологии; Том 5, № 2 (2018); 62-70 ; 2413-3787 ; 2313-805X ; 10.17650/2313-805X-2018-5-2
مصطلحات موضوعية: cancer-testis genes, multiple myeloma, overall survival, progression-free survival, раково-тестикулярный ген, множественная миелома, общая выживаемость, безрецидивная выживаемость
وصف الملف: application/pdf
Relation: https://umo.abvpress.ru/jour/article/view/149/143; Scanlan M. J., Simpson A. J., Old L. J. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004;4:1. PMID: 14738373.; Chen Y. T., Scanlan M. J., Sahin U. et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94(5):1914–8. PMID: 9050879.; Scanlan M. J., Gure A. O., Jungbluth A. A. et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002;188:22–32. PMID: 12445278.; Simpson A. J., Caballero O. L., Jungbluth A. et al. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005;5(8):615–25. DOI:10.1038/nrc1669. PMID: 16034368.; Mirandola L., Cannon M. J., Cobos E. et al. Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Int Rev Immunol 2011;30(2–3):127–37. DOI:10.3109/08830185.2011.572504. PMID: 21557639.; Мисюрин В. А. Х-хромосомные раково-тестикулярные гены. Российский биотерапевтический журнал 2014;13(2):3–9.; Fratta E., Coral S., Covre A. et al. The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol 2011;5(2):164–82. DOI:10.1016/j.molonc.2011.02.001. PMID: 21376678.; Song M. H., Ha J. C., Lee S. M. et al. Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX. Biochem Biophys Res Commun 2011;408(2):195–201. DOI:10.1016/j.bbrc.2011.02.077. PMID: 21338577.; Chen Y. T., Ross D. S., Chiu R. et al. Multiple cancer/testis antigens are preferentially expressed in hormonereceptor negative and high-grade brease cancers. PLoS One 2011;6(3):17876. DOI:10.1371/journal.pone.0017876. PMID: 21437249.; Boss D. S., Glen H., Beijnen J. H. et al. Serum β-HCG and CA-125 as tumor markers in a patient with osteosarcoma: case report. Tumori 2011;97(12):109–14. PMID: 21528673.; Silina K., Zayakin P., Kalnina Z. et al. Sperm-associated antigens as targets for cancer immunotheraphy: expression pattern and humoral immune response in cancer patients. J Immunother 2011;34(1):28–44. DOI:10.1097/CJI.0b013e3181fb64fa. PMID: 21150711.; Maruyama M., Yoshitake Н.Т.Н., Takamori K., Araki Y. Molecular expression of Ly6k, a putative glycosylphosphatidyl- inositol-anchored membrane protein on the mouse testicular germ cells. Biochem Biophys Res Commun 2010;402(1):75–81. DOI:10.1016/j.bbrc.2010.09.117. PMID: 20920470.; Matsuda R., Enokida H., Chiyomaru T. et al. LY6K is a novel molecular target in blader cancer on basis of integrate genome-wide profiling. Br J Cancer 2011;104(2):376–86. DOI:10.1038/sj.bjc.6605990. PMID: 21063397.; Li F. Q., Liu Q., Han Y. L. et al. Sperm protein 17 is highly expressed in endometrial and cervical cancers. BMC Cancer 2010;10:429. DOI:10.1186/1471-2407-10-429. PMID: 20712874.; Demento S. L., Siefert A. L., Bandyopadhyay A. et al. Pathogenassociated molecular patterns on biomaterials: a paradigm for engineering new vaccines. Trends Biotechnol 2011;29(6):294–306. DOI:10.1016/j.tibtech.2011.02.004. PMID: 21459467.; Forghanifard M. M., Gholamin M., Farshchian M. et al. Cancer-testisgene expression profiling in esophageal squamous cell carcinoma: identificationof specific tumor marker and potential targets for immunotherapy. Cancer Biol Ther 2011;12(3):191–7. PMID: 21613820.; Gaugler B., van den Eynde B., van der Bruggen P. et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179(3):921–30. PMID: 8113684.; Ng А.К. Diffuse large B-cell lymphoma. Semin Radiat Oncol 2007;17(3):169–75. DOI:10.1016/j.semradonc.2007.02.002. PMID: 17591563.; Weigert O., Unterhalt M., Hiddemann W., Dreyling M. Current man-agement of mantle cell lymphoma. Drugs 2007;67(12):1689–702. PMID: 17683170.; Richardson P. G., Mitsiades C., Schlossman R. et al. New drugs for myeloma. Oncologist 2007;12(6):664–89. DOI:10.1634/theoncologist.12-6-664. PMID: 17602058.; Harris N. L., Jaffe E. S., Diebold J. et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999;10(12):1419–32. PMID: 10643532.; Veelken H., Osterroth F. Vaccination strategies in the treatment of lymphomas. Oncology 2002;62(3):187–200. DOI:10.1159/000059565. PMID: 12065865.; Bogen B., Ruffini P. A., Corthay A. et al. Idiotype-specific immu-notherapy in multiple myeloma: suggestions for future directions of research. Haematologica 2006;91(7):941–8. PMID: 16818282.; Richardson P. G., Sonneveld P., Schuster M. et al. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-toevent results of the APEX trial. Blood 2007;110(10): 3557–60. DOI:10.1182/blood-2006-08-036947. PMID: 17690257.; Engelhardt M., Udi J., Kleber M. et al. European myeloma network: the 3rd Trialist forum consensus statement from the European experts meeting on multiple myeloma. Leuk Lymphoma 2010;51(11):2006–11. DOI:10.3109/10428194.2010.516378. PMID: 20807087.; Kono K., Mizukami Y., Daigo Y. et al. Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 2009;100(8):1502–9.; Barlogie B., Shaughnessy J., Tricot G. et al. Treatment of multiple myeloma. Blood 2004;103(1):20–32. DOI:10.1182/blood-2003-04-1045. PMID: 12969978.; Bakkus M. H., Bouko Y., Samson D. et al. Post-transplantation tumour load in bone marrow, as assessed by quantitative ASOPCR, is a prognostic parameter in multiple myeloma. Br J Haematol 2004; 126(5):665–74. DOI:10.1111/j.1365-2141.2004.05120.x. PMID: 15327517.; van Rhee F., Szmania S. M., Zhan F. et al. NY-ESO-1 is highly expressed in poorprognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood 2005;105(10):3939–44. DOI:10.1182/blood-2004-09-3707. PMID: 15671442.; van Duin M., Broy A., de Knegt Y. et al. Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy. Haematologica 2011;96(11):1662–9. DOI:10.3324/haematol.2010.037978. PMID: 21791470.; https://umo.abvpress.ru/jour/article/view/149
-
3Academic Journal
المؤلفون: Bobrov, A. E., Starostina, E. G., Agamamedova, I. N., Volodina, M. N., Karacheva, Yu. V., Nikitina, T. E., Parpara, M. A., Subbotnikova, O. A., Tsarenko, D. M., Nouwen, A., Lloyd, C., Sartorius, N.
Relation: https://oro.open.ac.uk/78930/1/Bobrov%20et%20al%20%28inc%20Lloyd%29_Mental%20Disorders%20in%20Diabetes.pdf; https://oro.open.ac.uk/78930/
-
4Academic Journal
المؤلفون: Glazova, N., Merchieva, S., Volodina, M., Sebentsova, E., Manchenko, D., Kudrun, V., Levitskaya, N.
وصف الملف: text/html
-
5Academic Journal
المؤلفون: Volodina, M., Sebentsova, E., Glazova, N., Manchenko, D., Inozemtseva, L., Dolotov, O., Andreeva, L., Levitskaya, N., Kamensky, A., Myasoedov, N.
وصف الملف: text/html
-
6
المؤلفون: Khashchenko E.P. Khashchenko, Uvarova E.V. Uvarova, Vysokikh M.Yu. Vysokikh, Pyataeva S.V. Pyataeva, Sukhanova Yu.A. Sukhanova, Tarasova N.V. Tarasova, Volodina M.A. Volodina M, Tsvirkun D.V. Tsvirkun
المصدر: Akusherstvo i ginekologiia. :104-113
مصطلحات موضوعية: business.industry, medicine, Physiology, General Medicine, Overweight, medicine.symptom, business, Polycystic ovary
-
7Academic Journal
المؤلفون: El’chaninov, A. V., Volodina, M. A., Arutyunyan, I. V., Makarov, A. V., Tarasova, N. V., Kananykhina, E. Yu., Usman, N. Yu., Marei, M. V., Vysokikh, M. Yu., Glinkina, V. V., Bol’shakova, G. B., Fatkhudinov, T. H., Sukhikh, G. T.
المصدر: Bulletin of Experimental Biology and Medicine ; volume 158, issue 4, page 566-572 ; ISSN 0007-4888 1573-8221
-
8Academic Journal
المصدر: Neuroscience and Behavioral Physiology ; volume 42, issue 4, page 362-369 ; ISSN 0097-0549 1573-899X
-
9Academic Journal
المؤلفون: Volodina, M. A., Sebentsova, E. A., Glazova, N. Y., Levitskaya, N. G., Andreeva, L. A., Manchenko, D. M., Kamensky, A. A., Myasoedov, N. F.
المصدر: Bulletin of Experimental Biology and Medicine ; volume 152, issue 5, page 560-563 ; ISSN 0007-4888 1573-8221
-
10Academic Journal
المؤلفون: Nikulin, A., Aleksandrova, I., Ivanchik, N., Nehaeva, G., Polikarpova, S., Safronova, E., Shulkina, T., Volodina, M., Dekhnich, A.
المصدر: International Journal of Antimicrobial Agents ; volume 34, page S50 ; ISSN 0924-8579
-
11Academic Journal
المؤلفون: Sukhanova, Yu. A., Volodina, M. A., Sebentsova, E. A., Glazova, N. Yu., Manchenko, D. M., Inozemtseva, L. S., Andreeva, L. A., Dolotov, O. V., Levitskaya, N. G.
المصدر: Neurochemical Journal; Jan2018, Vol. 12 Issue 1, p53-63, 11p
-
12Academic Journal
المؤلفون: Volodina, M. A., Gorshkova, T. A., Maky, Abubakr K.T.
المصدر: Analytical Letters ; volume 10, issue 14, page 1189-1194 ; ISSN 0003-2719 1532-236X
-
13Academic Journal
المؤلفون: Volodina, M. A.
المصدر: Soviet Education ; volume 4, issue 11, page 47-50 ; ISSN 0038-5360
-
14Academic Journal
المؤلفون: Ievlev, V., Kannykin, S., Il'inova, T., Volodina, M., Bobrinskaya, E., Baikin, A., Vavilova, V., Serikov, D.
المصدر: Inorganic Materials; Jul2016, Vol. 52 Issue 7, p677-685, 9p
مصطلحات موضوعية: CRYSTALLIZATION, MECHANICAL behavior of materials, AMORPHOUS substances, IRON alloys, CORROSION resistance
-
15Academic Journal
المؤلفون: Eremina, E., Kapusta, D., Volodina, M., Sidorov, A., Grigorieva, A., Goodilin, E.
المصدر: Nanotechnologies in Russia; Sep2015, Vol. 10 Issue 9/10, p713-726, 14p
-
16Academic Journal
المؤلفون: El'chaninov, A., Volodina, M., Arutyunyan, I., Makarov, A., Tarasova, N., Kananykhina, E., Usman, N., Marei, M., Vysokikh, M., Glinkina, V., Bol'shakova, G., Fatkhudinov, T., Sukhikh, G.
المصدر: Bulletin of Experimental Biology & Medicine; Feb2015, Vol. 158 Issue 4, p566-572, 7p
مصطلحات موضوعية: LIVER regeneration, STROMAL cells, MITOCHONDRIA, UMBILICAL cord, LIVER cells, CELL proliferation, LABORATORY rats
-
17Academic Journal
المؤلفون: Volodina, M.1, Merchieva, S.1, Sebentsova, E.2, Glazova, N.2, Manchenko, D.1, Andreeva, L.2, Levitskaya, N.2 nglevitskaya@gmail.com, Kamensky, A.1, Myasoedov, N.2
المصدر: Biology Bulletin. Jul2014, Vol. 41 Issue 4, p372-377. 6p.
مصطلحات موضوعية: *FLUVOXAMINE, *DRUG administration, *SEROTONIN uptake inhibitors, *LABORATORY rats, *INTRAPERITONEAL injections, *BODY weight
-
18Academic Journal
المؤلفون: Omel'chenko, K. G., Volodina, M. V.
المصدر: Journal of Engineering Physics ; volume 29, issue 1, page 860-862 ; ISSN 0022-0841 1573-871X
-
19Academic Journal
المؤلفون: Volodina, M. A., Terent'ev, A. P., Kudryashova, V. A.
المصدر: Chemistry of Heterocyclic Compounds ; volume 2, issue 2, page 225-226 ; ISSN 0009-3122 1573-8353
-
20